The past has been hard because TIS thought (maybe with reasonable grounds) that they could get their product approved by the EU as a device. At the time I was surprised, but I thought well why not do it if we can.
Now we are going the more formal fda clinical trials route. But this means that the world's biggest market will now be available. Also there is much more proof of efficacy when the fda gives the thumbs up.
I know that no clinical trials are a given. But we do know that ftt's product is safe, it does work and has little competition - so it's a pretty good bet.
It's such an easy product to sell too, as it saves health authorities a fortune.
So I think now is the time to fill your boots, and then stash your share certificates away and wait for the 50% tax reduction on capital gains.
Cheers
TIS Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
